Skip to content

Martina Di Simplicio

2 papers in the library · publishing 2015-2026

Papers

Sort Most recent Most cited

Exploring new avenues: Psychedelic-assisted therapy for young people.

British Journal of Clinical Pharmacology May 8, 2026 Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David Nutt et al.

Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic-assisted therapy, using substances such as psilocybin and 3,4-methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including depression, anxiety and post-traumatic stress...

DOI: 10.1002/bcp.70579 (opens in new tab) Full text (opens in new tab) Adolescents Psychedelics Psychedelic‐assisted therapy Young people

How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia.

Schizophrenia Bulletin March 2015 Daniel Freeman, Graham Dunn, Robin Murray et al.

Paranoia is receiving increasing attention in its own right, since it is a central experience of psychotic disorders and a marker of the health of a society. Paranoia is associated with use of the most commonly taken illicit drug, cannabis. The objective was to determine whether the principal psychoactive ingredient of cannabis-∆(9)-tetrahydrocannabinol (THC)-causes paranoia and to use the drug...